Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

Clinical trial NCT04401774 · COMPLETED

Trial details

NCT number

NCT04401774

Sponsor

Memorial Sloan Kettering Cancer Center

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2020-05-22

Primary completion

2026-01-22

Enrollment

14

View on ClinicalTrials.gov